28.71 USD
↘ 0.42 (1.44%)AT CLOSE (11:59 AM EDT)
GH Research PLC Ordinary Shares
GHRSNASDAQ • USD
28.67
↘ 0.05 (0.16%)
POST MARKET (AS OF 06:08 PM EDT)
Post Market
AS OF 06:08 PM EDT
28.67
↘ 0.05 (0.16%)
Market: CLOSED
GH Research PLC Ordinary Shares (GHRS) trades at $28.78 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, a bullish Golden Cross on the moving averages and bullish moving average alignment.
Technical & fundamental data as of Jul 17, 2026.
Open?$28.75
High?$30.59
Low?$27.50
Prev. Close?$29.13
Volume?637.5K
Avg. Volume?N/A
VWAP?$29.23
Bid / Ask
Bid?$24.08 × 100
Ask?$34.79 × 100
Spread?$10.71
Midpoint?$29.44
Valuation & Ratios
Market Cap?2.0B
Shares Out?68.6M
Float?45.2M
Float %?72.9%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?63
Piotroski F-Score?0/9Weak
Altman Z-Score?250.67Safe
Confidence?31%Very Low
Short InterestHigh
Short % of Float?4.28%Low
Short Interest?1.9M
Days to Cover?6.6
Free Float45.2M
Avg Daily Volume295.2K
Settlement Date2026-06-30